• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful Slow Desensitization to Tocilizumab in a 15-Year-Old Patient.

作者信息

Cansever M, Şahin N, Dursun I, Geyik C, Düşünsel R, Bektaş Kut F, Tahan F

机构信息

Erciyes University, School of Medicine, Department of Pediatrics, Division of Allergy, Kayseri, Turkey.

Erciyes University, School of Medicine, Department of Pediatrics, Division of Rheumatology, Kayseri, Turkey.

出版信息

J Investig Allergol Clin Immunol. 2018 Dec;28(6):436-438. doi: 10.18176/jiaci.0314.

DOI:10.18176/jiaci.0314
PMID:30530397
Abstract
摘要

相似文献

1
Successful Slow Desensitization to Tocilizumab in a 15-Year-Old Patient.一名15岁患者成功实现对托珠单抗的缓慢脱敏
J Investig Allergol Clin Immunol. 2018 Dec;28(6):436-438. doi: 10.18176/jiaci.0314.
2
Successful rapid tocilizumab desensitization in a patient with Still disease.一名斯蒂尔病患者成功进行了快速托珠单抗脱敏治疗。
J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):631-2. doi: 10.1016/j.jaip.2014.04.015. Epub 2014 Jun 2.
3
Effective Desensitization to Tocilizumab in Delayed Hypersensitivity Reaction.托珠单抗治疗迟发性过敏反应的脱敏作用。
Pharmacology. 2018;102(1-2):114-116. doi: 10.1159/000490419. Epub 2018 Jun 28.
4
Posterior reversible encephalopathy syndrome during treatment with tocilizumab in juvenile idiopathic arthritis.托珠单抗治疗幼年特发性关节炎期间的后部可逆性脑病综合征
Arq Neuropsiquiatr. 2018 Oct;76(10):720-721. doi: 10.1590/0004-282X20180093.
5
Tocilizumab for treating juvenile idiopathic arthritis.托珠单抗治疗幼年特发性关节炎。
Expert Opin Biol Ther. 2016;16(4):559-66. doi: 10.1517/14712598.2016.1150997. Epub 2016 Feb 27.
6
[Tocilizumab for refractory systemic juvenile idiopathic arthritis].托珠单抗治疗难治性全身型幼年特发性关节炎
Zhonghua Er Ke Za Zhi. 2017 Nov 2;55(11):830-834. doi: 10.3760/cma.j.issn.0578-1310.2017.11.008.
7
Successful treatment with tocilizumab of a psoriasiform skin lesion induced by etanercept in a patient with juvenile idiopathic arthritis.用托珠单抗成功治疗一名幼年特发性关节炎患者因依那西普诱发的银屑病样皮肤病变。
Mod Rheumatol. 2015;25(6):972-3. doi: 10.3109/14397595.2014.985812. Epub 2014 Dec 15.
8
Guidance on using tocilizumab for juvenile idiopathic arthritis.托珠单抗治疗幼年特发性关节炎的指导建议。
Mod Rheumatol. 2011 Dec;21(6):563-71. doi: 10.1007/s10165-011-0464-1. Epub 2011 May 20.
9
Subcutaneous panniculitis-like T-cell lymphoma with haemophagocytic syndrome during tocilizumab therapy for juvenile idiopathic arthritis.在托珠单抗治疗幼年特发性关节炎期间发生的伴有噬血细胞综合征的皮下脂膜炎样T细胞淋巴瘤。
Clin Exp Rheumatol. 2017 Jan-Feb;35(1):174. Epub 2017 Jan 5.
10
Tocilizumab for systemic juvenile idiopathic arthritis.托珠单抗治疗全身型幼年特发性关节炎。
N Engl J Med. 2013 Mar 28;368(13):1256-7. doi: 10.1056/NEJMc1301017.

引用本文的文献

1
Desensitization to Tocilizumab in a Patient With Juvenile Idiopathic Arthritis.一名幼年特发性关节炎患者对托珠单抗脱敏治疗
Cureus. 2025 Mar 24;17(3):e81084. doi: 10.7759/cureus.81084. eCollection 2025 Mar.
2
Adverse events associated with monoclonal antibodies used for treatment of COVID-19: A systematic review and meta-analysis.与用于治疗COVID-19的单克隆抗体相关的不良事件：一项系统评价和荟萃分析。
Br J Clin Pharmacol. 2025 May;91(5):1306-1321. doi: 10.1002/bcp.70025. Epub 2025 Mar 6.
3
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS).
新型伊度沙酶和拉罗尼酶脱敏治疗 2 型和 1 型黏多糖贮积症（MPS）。
Orphanet J Rare Dis. 2022 Nov 3;17(1):402. doi: 10.1186/s13023-022-02556-7.
4
Immune-related adverse events of biological immunotherapies used in COVID-19.用于治疗新冠肺炎的生物免疫疗法的免疫相关不良事件。
Front Pharmacol. 2022 Aug 25;13:973246. doi: 10.3389/fphar.2022.973246. eCollection 2022.
5
Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement.实用静脉内快速药物脱敏和去标签标准：WAO委员会声明
World Allergy Organ J. 2022 May 31;15(6):100640. doi: 10.1016/j.waojou.2022.100640. eCollection 2022 Jun.
6
Retrospective analyzes of adverse events during biologic agents in children with juvenile idiopathic arthritis from a single center in Turkey.对土耳其单中心青少年特发性关节炎患儿使用生物制剂期间不良事件的回顾性分析。
Reumatologia. 2020;58(6):367-374. doi: 10.5114/reum.2020.102001. Epub 2020 Dec 23.
7
Desensitization to biological agents used in rheumatology.对风湿病学中使用的生物制剂的脱敏作用。
Reumatologia. 2020;58(1):25-33. doi: 10.5114/reum.2020.93510. Epub 2020 Feb 28.
8
Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.托珠单抗诱导成人斯蒂尔病和全身型幼年特发性关节炎患者发生过敏反应：基于病例的综述
Rheumatol Int. 2020 May;40(5):791-798. doi: 10.1007/s00296-019-04456-9. Epub 2019 Oct 9.